Aurora Spine Corporation, a leader in minimally invasive spine and interventional pain solutions, announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation.

The establishment of Aurora Biologics creates seamless synergy across Aurora’s growing spine ecosystem—including its renowned interspinous, lumbar, and sacroiliac fusion systems such as ZIP™, Hydra A.E.R.O.™, DEXA™, and SiLO™ portfolios. These mechanical and regenerative technologies now converge within one integrated platform designed to enhance patient outcomes, improve surgical efficiency, and promote long-term fusion integrity.

Aurora Biologics launches with a complete suite of allograft solutions, including:

TURBO FUSE™ Fibre Putty – a bone graft substitute composed of demineralised bone fibres that increase surface area and promote cellular attachment.

OSTEO GRAFT™ DBM Putty – a demineralised cortical bone graft with a cohesive, moldable consistency to support bone formation without synthetic carriers.

OSTEO BRIDGE™ Sponge Strips – a sponge-like bone graft substitute that conforms to patient anatomy and fills bone voids to support structural regeneration.

Each biologic is formulated from 100 per cent allograft bone, free of synthetic carriers, delivering natural osteoconductive and osteoinductive properties for predictable, high-quality bone growth. Fully moldable and cohesive, these materials are designed to fill bony defects or augment fusion sites, providing a natural biologic scaffold for bone regeneration.

Engineered to work synergistically with Aurora’s implant technologies, the Aurora Biologics line creates a comprehensive, biologically active fusion environment that optimises outcomes for both patients and surgeons.